Adams William A. 4

What Happened

• William A. Adams, a director of National Healthcare Corp (NHC), received a grant of 7,500 derivative securities on May 7, 2026. The Form 4 reports the acquisition at $0.00 because this was an award of stock options (a derivative grant), not an open-market purchase. The filing does not list an aggregate market value or the exercise price in the summary provided.

Key Details

• Transaction date: 2026-05-07 (filed the same day).
• Transaction type: Award/Grant of derivative securities (stock options); reported price $0.00.
• Shares/options acquired: 7,500 stock options (derivative).
• Shares owned after transaction: Not specified in the provided summary.
• Footnote: Options were granted under the 2020 Omnibus Equity Incentive Plan and the grant and exercise are stated to be exempt from Section 16(b) under Rule 16b-3(d) (routine director compensation).
• Timeliness: Filing date matches transaction date (appears timely).

Context

• This is a routine equity compensation grant to a director. Stock options give the holder the right to buy company shares in the future at a set exercise price (the exercise price and vesting schedule were not included in the summary provided). Such grants are common as part of director compensation and do not by themselves indicate an insider buying or selling shares in the open market.